Dynavax Historical Financial Ratios
| DVAX Stock | USD 11.42 0.34 2.89% |
Dynavax Technologies is recently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.48 or Days Sales Outstanding of 103 will help investors to properly organize and evaluate Dynavax Technologies financial condition quickly.
Dynavax |
About Dynavax Financial Ratios Analysis
Dynavax TechnologiesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Dynavax Technologies investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Dynavax financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Dynavax Technologies history.
Dynavax Technologies Financial Ratios Chart
Dynavax Technologies financial ratios usually calculated using numerical values taken directly from Dynavax Technologies financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Dynavax Technologies. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Dynavax Technologies' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to rise to 19.59 in 2024, whereas Price To Sales Ratio is likely to drop 7.36 in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Dynavax Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Dynavax Technologies sales, a figure that is much harder to manipulate than other Dynavax Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Dynavax Technologies. There are two different methods for calculating Dynavax Technologies invested capital: operating approach and financing approach. Understanding Dynavax Technologies invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Dynavax Technologies' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to rise to 19.59 in 2024, whereas Price To Sales Ratio is likely to drop 7.36 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 66.76 | 81.64 | 9.56 | 10.55 | Days Of Inventory On Hand | 128.98 | 82.77 | 387.72 | 726.55 |
Dynavax Technologies fundamentals Correlations
Click cells to compare fundamentals
Dynavax Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dynavax Technologies fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 11.7 | 9.63 | 3.72 | 1.86 | 7.75 | 7.36 | |
| Ptb Ratio | 49.7 | 7.64 | 7.36 | 2.31 | 2.89 | 4.48 | |
| Days Sales Outstanding | 92.09 | 177.68 | 109.49 | 74.5 | 69.98 | 103.42 | |
| Book Value Per Share | 0.12 | 0.58 | 1.91 | 4.6 | 4.83 | 5.07 | |
| Free Cash Flow Yield | (0.37) | (0.23) | 0.2 | 0.0413 | 0.0536 | 0.0563 | |
| Invested Capital | 26.48 | 3.71 | 1.16 | 0.44 | 0.41 | 0.39 | |
| Operating Cash Flow Per Share | (1.68) | (0.92) | 2.89 | 0.5 | 0.78 | 0.82 | |
| Stock Based Compensation To Revenue | 0.72 | 0.29 | 0.0484 | 0.0455 | 0.18 | 0.17 | |
| Pb Ratio | 49.7 | 7.64 | 7.36 | 2.31 | 2.89 | 4.48 | |
| Ev To Sales | 16.71 | 13.62 | 3.32 | 1.94 | 8.21 | 7.8 | |
| Free Cash Flow Per Share | (2.09) | (1.03) | 2.8 | 0.44 | 0.75 | 0.79 | |
| Roic | (0.53) | (0.33) | 0.28 | 0.34 | (0.0616) | (0.0647) | |
| Inventory Turnover | 0.47 | 0.22 | 2.83 | 4.41 | 0.94 | 1.49 | |
| Net Income Per Share | (2.1) | (0.91) | 0.66 | 2.32 | (0.0496) | (0.0521) | |
| Days Of Inventory On Hand | 778.08 | 1.7K | 128.98 | 82.77 | 387.72 | 726.55 | |
| Payables Turnover | 2.09 | 4.2 | 66.76 | 81.64 | 9.56 | 10.55 | |
| Research And Ddevelopement To Revenue | 1.77 | 0.61 | 0.0733 | 0.0645 | 0.24 | 0.22 | |
| Capex To Revenue | (0.83) | (0.24) | (0.0216) | (0.009878) | (0.0177) | (0.0186) | |
| Cash Per Share | 2.1 | 1.64 | 4.7 | 4.94 | 5.77 | 5.48 | |
| Pocfratio | (3.4) | (4.86) | 4.88 | 21.44 | 17.9 | 18.79 | |
| Interest Coverage | (7.16) | (3.95) | 12.03 | 42.12 | (5.48) | (5.75) | |
| Pfcf Ratio | (2.73) | (4.34) | 5.02 | 24.2 | 18.66 | 19.59 | |
| Days Payables Outstanding | 174.66 | 86.91 | 5.47 | 4.47 | 38.16 | 36.25 | |
| Roe | (18.26) | (1.56) | 0.34 | 0.5 | (0.0103) | (0.0108) | |
| Ev To Operating Cash Flow | (4.85) | (6.87) | 4.34 | 22.34 | 18.96 | 19.9 | |
| Return On Tangible Assets | (0.55) | (0.26) | 0.074 | 0.3 | (0.006421) | (0.006742) | |
| Ev To Free Cash Flow | (3.91) | (6.14) | 4.47 | 25.21 | 19.76 | 20.75 | |
| Intangibles To Total Assets | 0.0164 | 0.006502 | 0.002045 | 0.002035 | 0.002073 | 0.001969 | |
| Net Debt To E B I T D A | (1.54) | (2.77) | (1.26) | 0.19 | 5.08 | 5.34 | |
| Current Ratio | 3.63 | 2.95 | 1.09 | 4.56 | 13.81 | 6.97 | |
| Tangible Book Value Per Share | 0.0515 | 0.56 | 1.89 | 4.58 | 4.82 | 5.06 | |
| Receivables Turnover | 3.96 | 2.05 | 3.33 | 4.9 | 5.22 | 9.22 | |
| Graham Number | 2.33 | 3.46 | 5.33 | 15.49 | 2.32 | 2.21 | |
| Shareholders Equity Per Share | 0.12 | 0.58 | 1.91 | 4.6 | 4.83 | 5.07 |
Pair Trading with Dynavax Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.Moving against Dynavax Stock
| 0.66 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.66 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.63 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.57 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.53 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.